GLP-1 drugs can quiet hunger. But experts say the psychology of eating still matters

GLP-1 weight loss drugs such as Ozempic and Wegovy have changed the way millions of people experience hunger. But while these medications can suppress appetite, experts say long-term eating habits are shaped by far more than biology alone.

GLP-1 medications including Ozempic, Wegovy and Mounjaro have transformed obesity treatment, helping millions of people lose weight by reducing appetite and quieting the persistent ‘food noise’ that can make dieting feel impossible. For many, the results have been life-changing.

Yet as the popularity of these medications continues to grow, psychologists and clinicians are asking a new question: what happens after hunger is no longer the biggest challenge?

Eating behaviour is shaped by far more than appetite alone. Stress, poor sleep, emotional regulation, habit formation and the brain’s reward system all influence when, why and how we eat. While GLP-1 drugs can successfully reduce the biological drive to eat, they don’t necessarily address the psychological patterns that develop over years—or even decades.

“Appetite is not the enemy,” says Yimei Qin, founder of Qin’s Clinic on London’s Harley Street and a Traditional Chinese Medicine practitioner with more than 30 years of clinical experience. “It’s a signal. The question I always ask is: What is the body trying to communicate?”

When eating is about more than hunger

Modern research has shown that eating behaviour is influenced by far more than physical hunger. Poor sleep can alter hunger hormones, chronic stress can increase cravings for energy-dense foods, and emotional distress often changes the way people relate to food altogether.

For many people, eating becomes intertwined with comfort, routine, reward or stress relief. That means addressing weight isn’t always simply a matter of reducing appetite. Qin says this reflects what she sees every day in clinical practice.

“Patients rarely come in with just one concern,” she says. “They often describe poor sleep, digestive issues, persistent fatigue, hormonal disruption and heightened stress responses alongside concerns about their weight.”

Rather than viewing these as isolated problems, she believes they often represent different expressions of a broader disruption in the body’s ability to regulate itself.

The role of stress

One recurring pattern Qin identifies is chronic stress. “A patient whose stress response is chronically elevated, whose sleep is fragmented and whose digestion is sluggish is not experiencing three entirely separate problems,” she says. “In my view, they may be experiencing different expressions of the same underlying imbalance.”

While Traditional Chinese Medicine explains these relationships through its own diagnostic framework, many aspects of the connection between stress and eating behaviour are also recognised within conventional medicine. Chronic stress can influence food choices, disrupt sleep, reduce energy levels and make healthy routines more difficult to sustain.

This is why many healthcare professionals now view obesity as a complex condition influenced by biology, psychology and environment—not simply a matter of willpower.

Suppression versus self-regulation

Qin is careful to acknowledge the benefits of GLP-1 medications. “For many people, the relief of no longer feeling driven by constant hunger is real and significant,” she says. “These drugs have a legitimate role in medicine.”

But she believes the conversation shouldn’t end there. “When it comes to appetite dysregulation, the question isn’t simply, ‘How do we reduce appetite?’ It’s also, ‘Why has the body’s ability to regulate itself been disrupted in the first place?'”

That concept of self-regulation sits at the centre of her clinical philosophy. Rather than focusing solely on suppressing symptoms, she aims to understand the wider context surrounding each patient’s health—including sleep, stress, digestion, hormonal changes and personal history.

“My aim is to support the body’s own capacity to find balance again,” she says.

Looking at the whole picture

Qin does not position Traditional Chinese Medicine as an alternative to evidence-based medical treatment. Instead, she sees it as asking a different set of questions.

“I have no interest in positioning Traditional Chinese Medicine against modern medicine,” she says. “Modern medicine is often highly effective at targeted intervention. Traditional Chinese Medicine often begins by asking why the pattern has become disordered.”

For patients using GLP-1 medications, that broader perspective may complement — not replace — their medical care. Lifestyle changes, psychological support, improved sleep and stress management are increasingly recognised as important parts of long-term health, regardless of whether medication is involved.

As obesity treatment continues to evolve, experts increasingly agree that successful care involves more than changing what’s happening in the stomach. It also means understanding what’s happening in the mind.

“The most important first step,” Qin says, “may be a fuller conversation —one that looks not only at appetite, but at sleep, stress, digestion, hormones, medical history and the wider pattern of health.”

GLP-1 medications may have changed the science of weight loss, but they have also highlighted something deeper: reducing hunger is only one part of understanding why people eat. For many clinicians, the next chapter in obesity care is likely to be as much about psychological resilience and self-regulation as it is about appetite itself.

Words: Lucy Rawlinson, Images: Shutterstock